Current Edition

Reaping the Rewards of Structured Content Management in R&D Regulatory Operations: Preparation is Everything

Investing in structured content management and authoring capabilities without making sure there is a supporting backbone first is a bit like owning a Porsche when there are no suitable roads to drive on, yet life sciences firms are embracing the potential with great expectation and more than a little impatience. AMPLEXOR’s Agnes Cwienczek issues a reminder that the journey towards structured content authoring could involve a 15-year roadmap, and substantial progress cannot be made until companies have the right foundations in place.

[gview file=””]